Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning

Intubation Prediction in Sars-CoV-2 Patients Treated With Awake Prone Positioning

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05060926

Acronym

Intub_prone

Enrollment

Registered

2021-09-29

Start date

2021-09-16

Completion date

2022-04-30

Last updated

2022-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Hypoxemic Respiratory Failure, SARS-CoV-2 Virus

Brief summary

Retrospective study in Sars-Cov 2 patients hospitalised in ICU. We aim to explore the effects of Awake prone positioning on oxygenation and intubation rate.

Interventions

PROCEDUREAwake prone positioning

Awake prone position as long as possible according to the patients' tolerance

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Sars-CoV-2 pneumonia * ICU stay * Severe hypoxemia but non intubated

Exclusion criteria

* Intubated before admission * Denied consent for data analysis * Do not intubate order at ICU admission

Design outcomes

Primary

Measure	Time frame
Intubation rate	Once between ICU admission and extubation

Secondary

Measure	Time frame
Alveolo-arterial gradient change	Within 6 hours before and 6 hours after each pronation
Blood gas analysis	Within 6 hours before and 6 hours after each pronation
Respiratory pattern	Within 6 hours before and 6 hours after each pronation
Mortality	Up to 28 days from ICU admission

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026